应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01093 石药集团
休市中 12-20 16:08:10
4.810
+0.030
+0.63%
最高
4.850
最低
4.750
成交量
9,538万
今开
4.760
昨收
4.780
日振幅
2.09%
总市值
559.79亿
流通市值
559.79亿
总股本
116.38亿
成交额
4.58亿
换手率
0.82%
流通股本
116.38亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
活力经济筑牢幸福根基——解码石家庄获评“2024最具幸福感城市”
媒体滚动 · 12-21 06:23
活力经济筑牢幸福根基——解码石家庄获评“2024最具幸福感城市”
石药集团回购610万股股份 总金额2928万港元
财中社 · 12-20 17:33
石药集团回购610万股股份 总金额2928万港元
【港股通】石药集团(01093)两款单克隆抗体药物偶联物获得临床试验批准
金吾财讯 · 12-20 17:27
【港股通】石药集团(01093)两款单克隆抗体药物偶联物获得临床试验批准
石药集团(01093)12月20日斥资2928.3万港元回购610万股
智通财经 · 12-20 17:21
石药集团(01093)12月20日斥资2928.3万港元回购610万股
石药(01093.HK)两款抗体药物偶联物临床试验获批
阿斯达克财经 · 12-20 17:11
石药(01093.HK)两款抗体药物偶联物临床试验获批
石药集团(01093.HK)SYH 9017获中国药监局批准临床试验
阿斯达克财经 · 12-20 17:04
石药集团(01093.HK)SYH 9017获中国药监局批准临床试验
石药集团SYS6043获临床试验批准
财中社 · 12-20 17:01
石药集团SYS6043获临床试验批准
石药集团(01093):SYS 6005(抗体药物偶联物)获临床试验批准
智通财经网 · 12-20 16:57
石药集团(01093):SYS 6005(抗体药物偶联物)获临床试验批准
石药集团(01093):司美格鲁肽长效注射液(SYH9017)获临床试验批准
智通财经 · 12-20 16:51
石药集团(01093):司美格鲁肽长效注射液(SYH9017)获临床试验批准
石药集团关联交易涉及相关成员公司签续租协议
财中社 · 12-19 18:42
石药集团关联交易涉及相关成员公司签续租协议
石药集团(01093)12月19日斥资2929.4万港元回购615万股
智通财经 · 12-19 17:14
石药集团(01093)12月19日斥资2929.4万港元回购615万股
石药集团12月18日获南向资金加仓2993.85万股
市场透视 · 12-19 09:30
石药集团12月18日获南向资金加仓2993.85万股
石药集团回购620万股股份 总金额2927万港元
财中社 · 12-18
石药集团回购620万股股份 总金额2927万港元
石药集团(01093)12月18日耗资2927万港元回购620万股
智通财经 · 12-18
石药集团(01093)12月18日耗资2927万港元回购620万股
石药(01093.HK)回购620万股 涉资2,927万元
阿斯达克财经 · 12-18
石药(01093.HK)回购620万股 涉资2,927万元
石药集团再度交易临床初期创新药产品,业绩承压下或调整研发策略
21世纪经济报道 · 12-17
石药集团再度交易临床初期创新药产品,业绩承压下或调整研发策略
石药集团(01093)12月17日斥资2932.5万港元回购630万股
智通财经 · 12-17
石药集团(01093)12月17日斥资2932.5万港元回购630万股
石药集团(01093)出现大手买入110万股,成交价$4.65,涉资511.5万
阿斯达克财经 · 12-17
石药集团(01093)出现大手买入110万股,成交价$4.65,涉资511.5万
蔡东晨增持石药集团(01093)100万股 每股作价约4.80港元
智通财经 · 12-16
蔡东晨增持石药集团(01093)100万股 每股作价约4.80港元
石药集团回购630万股 支付2936万港元
财中社 · 12-16
石药集团回购630万股 支付2936万港元
公司概况
公司名称:
石药集团
所属市场:
SEHK
上市日期:
--
主营业务:
石药集团有限公司是一家主要从事生产及销售药品的投资控股公司。该公司通过三个分部运营其业务。成药分部从事研发、生产及销售药品以及授权业务。原料产品分部从事生产及销售粉状维生素C及抗生素产品。功能食品及其他分部从事制造及销售功能食品产品(包括咖啡因食物添加剂、无水葡萄糖、阿卡波糖及维生素C含片)、提供医疗服务及其他。该公司的产品治疗领域包括神经系统、抗肿瘤、抗感染、心血管、呼吸系统、消化代谢等其他领域。该公司在国内和国外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"01093","market":"HK","secType":"STK","nameCN":"石药集团","latestPrice":4.81,"timestamp":1734682090014,"preClose":4.78,"halted":0,"volume":95376143,"delay":0,"floatShares":11638000000,"shares":11638000000,"eps":0.527529,"marketStatus":"休市中","marketStatusCode":7,"change":0.03,"latestTime":"12-20 16:08:10","open":4.76,"high":4.85,"low":4.75,"amount":458364769,"amplitude":0.020921,"askPrice":4.81,"askSize":14780000,"bidPrice":4.8,"bidSize":240000,"shortable":3,"etf":0,"ttmEps":0.46559814893716267,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734917400000},"adr":0,"listingDate":772128000000,"adjPreClose":4.78,"dividendRate":0.059391,"openAndCloseTimeList":[[1734658200000,1734667200000],[1734670800000,1734681600000]],"volumeRatio":0.8610549080082075,"optionData":{"bulkOrders":[{"symbol":"CSP.HK","call":true,"expireDate":1743091200000,"strike":"5.75","timestamp":1734676906522,"price":0.09000000357627869,"volume":600,"amount":108000,"type":"*"},{"symbol":"CSP.HK","call":true,"expireDate":1737907200000,"strike":"4.80","timestamp":1734676667616,"price":0.20000000298023224,"volume":319,"amount":127600,"type":"*"}]},"impliedVol":0.3042,"impliedVolPercentile":0.0891,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"CSP.HK"},"requestUrl":"/m/hq/s/01093/wiki","defaultTab":"wiki","newsList":[{"id":"2493470729","title":"活力经济筑牢幸福根基——解码石家庄获评“2024最具幸福感城市”","url":"https://stock-news.laohu8.com/highlight/detail?id=2493470729","media":"媒体滚动","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493470729?lang=zh_cn&edition=full","pubTime":"2024-12-21 06:23","pubTimestamp":1734733380,"startTime":"0","endTime":"0","summary":"转自:石家庄新闻网12月20日,振奋人心的喜讯传来——石家庄荣获“2024最具幸福感城市”。毫无疑问,经济高质量发展为“幸福石家庄”注入不竭动力与澎湃动能。“幸福石家庄”的产业支撑越来越有“力量”。创新,为“幸福石家庄”源源不断地注入新“能量”。统计显示,石药集团2021年研发费用首次超过30亿元,到2023年已达到50亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-12-21/doc-ineaeivz8504009.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1226287529.USD","LU1226288170.HKD","IE00BZ08YT58.USD","LU1226287792.SGD","LU1993786604.SGD","LU1226287875.USD","LU1226288253.USD","LU0326950275.SGD","LU0067412154.USD","BK1191","LU1152091754.HKD","IE0008369823.USD","01093","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","LU0501845795.SGD","LU0880133367.SGD","LU1960683339.HKD","SG9999004220.SGD","LU1008478684.HKD","LU1951186391.HKD","IE00B543WZ88.USD","LU0072913022.USD","BK1521","LU0140636845.USD","BK1515","LU1807302812.USD","IE00B5MMRT66.SGD","IE0008368742.USD","LU1152091168.USD","IE00B031HY20.USD"],"gpt_icon":0},{"id":"2492928794","title":"石药集团回购610万股股份 总金额2928万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492928794","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492928794?lang=zh_cn&edition=full","pubTime":"2024-12-20 17:33","pubTimestamp":1734687186,"startTime":"0","endTime":"0","summary":"财中社12月20日电石药集团(01093)发布公告,2024年12月20日,公司回购股份610万股,回购金额为2928万港元。根据回购授权的决议,公司可回购的股份总数为11.89亿股,已回购股份2.95亿股,占回购授权决议通过时已发行股份的2.48%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202412203274580977.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1226287529.USD","BK1191","LU1226288170.HKD","LU1226287875.USD","LU1951186391.HKD","IE00BZ08YR35.GBP","LU1152091754.HKD","LU1226287792.SGD","01093","IE00B543WZ88.USD","LU1807302812.USD","IE00BZ08YS42.EUR","BK1521","LU1008478684.HKD","IE00B5MMRT66.SGD","LU0067412154.USD","LU1993786604.SGD","LU0326950275.SGD","IE0008369823.USD","LU0880133367.SGD","LU0501845795.SGD","LU1960683339.HKD","LU1226288253.USD","LU1152091168.USD","BK1515","IE00BZ08YT58.USD","IE0008368742.USD","LU0140636845.USD","SG9999004220.SGD","IE00B031HY20.USD","LU0072913022.USD"],"gpt_icon":0},{"id":"2492492838","title":"【港股通】石药集团(01093)两款单克隆抗体药物偶联物获得临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2492492838","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492492838?lang=zh_cn&edition=full","pubTime":"2024-12-20 17:27","pubTimestamp":1734686868,"startTime":"0","endTime":"0","summary":"另外,集团开发的SYS 6043亦获国家药品监督管理局批准,可以在中国开展临床试验。临床前研究显示该产品对多种癌症均有较好的抗肿瘤作用,极有希望在后续临床试验中展现出良好的治疗效果。该产品已在国内外提交多项专利申请。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/MmQyODg0ZTE3OGFjNmIzNjJjMjUzNzk5MzM4MDk2Mjc3OQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MmQyODg0ZTE3OGFjNmIzNjJjMjUzNzk5MzM4MDk2Mjc3OQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1950092","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0501845795.SGD","LU1226288253.USD","IE0008369823.USD","IE00B031HY20.USD","LU1226287529.USD","LU1152091168.USD","BK1521","IE0008368742.USD","LU0880133367.SGD","LU0072913022.USD","BK1583","BK1515","HSTECH","IE00BZ08YS42.EUR","LU0067412154.USD","LU1807302812.USD","LU1226287792.SGD","01093","IE00BZ08YT58.USD","BK1576","BK1191","LU1008478684.HKD","BK1141","03347","LU1226288170.HKD","LU1951186391.HKD","YANG","IE00B543WZ88.USD","IE00B5MMRT66.SGD","LU1960683339.HKD","IE00BZ08YR35.GBP","LU1152091754.HKD","SG9999004220.SGD","LU0326950275.SGD","LU1226287875.USD","LU1993786604.SGD","HSCEI","LU0140636845.USD"],"gpt_icon":1},{"id":"2492946754","title":"石药集团(01093)12月20日斥资2928.3万港元回购610万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492946754","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492946754?lang=zh_cn&edition=full","pubTime":"2024-12-20 17:21","pubTimestamp":1734686484,"startTime":"0","endTime":"0","summary":"智通财经APP讯,石药集团(01093)发布公告,该公司于2024年12月20日斥资2928.3万港元回购610万股股份,每股回购价格为4.77-4.83港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1227699.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01093","BK1515","IE00B031HY20.USD","LU0072913022.USD","IE00B5MMRT66.SGD","LU0326950275.SGD","SG9999004220.SGD","LU1008478684.HKD","BK1521","LU0501845795.SGD","LU1226288253.USD","LU1807302812.USD","IE00BZ08YR35.GBP","LU1226287875.USD","LU1226287529.USD","LU1951186391.HKD","IE00B543WZ88.USD","BK1191","IE0008369823.USD","IE00BZ08YS42.EUR","LU0140636845.USD","LU1226288170.HKD","LU1960683339.HKD","LU1993786604.SGD","IE00BZ08YT58.USD","LU1152091754.HKD","IE0008368742.USD","LU0067412154.USD","LU1226287792.SGD","LU1152091168.USD","LU0880133367.SGD"],"gpt_icon":0},{"id":"2492494653","title":"石药(01093.HK)两款抗体药物偶联物临床试验获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2492494653","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492494653?lang=zh_cn&edition=full","pubTime":"2024-12-20 17:11","pubTimestamp":1734685860,"startTime":"0","endTime":"0","summary":"石药公布,集团所开发的抗体药物偶联物产品SYS6043及SYS6005,均已获中国国家药品监督管理局批准,可以在中国开展临床试验。SYS6043及SYS6005同为单克隆抗体药物偶联物,可与肿瘤表面的特异性受体结合,通过内吞作用进入细胞并释放毒素,达到杀伤肿瘤细胞的作用,均按照治疗用生物制品一类申报。而SYS6005获批适应症是晚期肿瘤,预计适用于治疗血液肿瘤、卵巢癌、非小细胞肺癌等。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220902171047369_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220902171047369_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1405644/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1191","LU1008478684.HKD","IE00BZ08YS42.EUR","LU1226288253.USD","LU1226288170.HKD","SG9999004220.SGD","LU0140636845.USD","LU0072913022.USD","IE00BZ08YR35.GBP","IE00B543WZ88.USD","LU1960683339.HKD","IE00B031HY20.USD","LU1152091168.USD","IE0008368742.USD","LU0880133367.SGD","BK1576","LU1951186391.HKD","BK1515","LU1226287875.USD","IE00B5MMRT66.SGD","LU0067412154.USD","IE0008369823.USD","03347","LU1152091754.HKD","LU0326950275.SGD","IE00BZ08YT58.USD","LU1226287529.USD","BK1141","LU1226287792.SGD","LU1993786604.SGD","01093","LU1807302812.USD","LU0501845795.SGD","BK1521","BK1583"],"gpt_icon":0},{"id":"2492966491","title":"石药集团(01093.HK)SYH 9017获中国药监局批准临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2492966491","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492966491?lang=zh_cn&edition=full","pubTime":"2024-12-20 17:04","pubTimestamp":1734685440,"startTime":"0","endTime":"0","summary":"石药集团(01093.HK) 公布,集团开发的GLP-1受体激动剂司美格鲁肽长效注射液(SYH 9017)已获中国国家药监局批准,可以在中国开展临床试验。本次获批的适应症为用于减少热量饮食和增加体力活动的基础上对成人超重或肥胖患者的体重管理。此外,该产品还具有治疗2型糖尿病以及降低心血管疾病风险的潜力,具有较高的临床开发价值。该产品是集团在GLP-1领域布局的首个每月给药一次的长效制剂。(sl/u)(港股报价延迟最少十五分钟。沽空资料截至 2024-12-20 16:25。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220902171048744_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220902171048744_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/analysis/china-hot-topic-content.aspx?id=NOW.1405634&catg=4&source=AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1583","LU1226287875.USD","IE00B543WZ88.USD","03347","LU1226287529.USD","BK1521","SG9999004220.SGD","IE0008368742.USD","LU0880133367.SGD","LU1226287792.SGD","LU0067412154.USD","BK1515","IE00BZ08YT58.USD","BK1576","LU1993786604.SGD","LU1008478684.HKD","LU1951186391.HKD","LU0501845795.SGD","IE00BZ08YS42.EUR","IE00B5MMRT66.SGD","01093","LU1226288253.USD","LU1807302812.USD","LU0072913022.USD","LU1960683339.HKD","IE0008369823.USD","IE00BZ08YR35.GBP","LU0326950275.SGD","LU1152091754.HKD","IE00B031HY20.USD","BK1141","LU1226288170.HKD","LU0140636845.USD","LU1152091168.USD","BK1191"],"gpt_icon":0},{"id":"2492914234","title":"石药集团SYS6043获临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2492914234","media":"财中社","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492914234?lang=zh_cn&edition=full","pubTime":"2024-12-20 17:01","pubTimestamp":1734685301,"startTime":"0","endTime":"0","summary":"财中社12月20日电石药集团(01093)发布自愿公告,宣布其开发的SYS6043(抗体药物偶联物)已获得中华人民共和国国家药品监督管理局批准,可以在中国开展临床试验。该产品是一款单克隆抗体药物偶联物,能够与肿瘤表面的特异性受体结合,通过内吞作用进入细胞并释放毒素,从而杀伤肿瘤细胞。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202412203274558252.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1226287792.SGD","LU1226288253.USD","LU1226287875.USD","IE0008368742.USD","IE00B5MMRT66.SGD","BK1191","SG9999004220.SGD","LU1951186391.HKD","LU1993786604.SGD","BK1515","01093","IE00BZ08YS42.EUR","LU0067412154.USD","LU1960683339.HKD","03347","LU1152091754.HKD","LU1226287529.USD","LU0326950275.SGD","LU0501845795.SGD","LU0140636845.USD","LU0880133367.SGD","LU0072913022.USD","LU1152091168.USD","LU1226288170.HKD","IE00BZ08YR35.GBP","IE00B031HY20.USD","IE0008369823.USD","LU1008478684.HKD","IE00BZ08YT58.USD","BK1576","BK1583","BK1141","BK1521","LU1807302812.USD","IE00B543WZ88.USD"],"gpt_icon":0},{"id":"2492499561","title":"石药集团(01093):SYS 6005(抗体药物偶联物)获临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2492499561","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492499561?lang=zh_cn&edition=full","pubTime":"2024-12-20 16:57","pubTimestamp":1734685057,"startTime":"0","endTime":"0","summary":"石药集团(01093)发布公告,本集团开发的SYS 6005(抗体药物偶联物(An...","market":"us","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_29.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_29.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1227662.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["IE00B031HY20.USD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","BK1141","IE00BZ08YR35.GBP","BK1191","LU1152091754.HKD","LU0072913022.USD","BK1583","IE00BZ08YS42.EUR","03347","IE0008369823.USD","SG9999004220.SGD","LU1226287529.USD","LU1226288170.HKD","BK1521","LU1807302812.USD","LU1993786604.SGD","IE00BZ08YT58.USD","LU0326950275.SGD","LU1226288253.USD","BK1576","LU1960683339.HKD","LU1951186391.HKD","LU0140636845.USD","LU0880133367.SGD","LU0067412154.USD","LU1226287792.SGD","01093","LU1008478684.HKD","LU1152091168.USD","LU1226287875.USD","LU0501845795.SGD","BK1515","IE0008368742.USD"],"gpt_icon":0},{"id":"2492496097","title":"石药集团(01093):司美格鲁肽长效注射液(SYH9017)获临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2492496097","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492496097?lang=zh_cn&edition=full","pubTime":"2024-12-20 16:51","pubTimestamp":1734684679,"startTime":"0","endTime":"0","summary":"智通财经APP讯,石药集团 发布公告,集团开发的GLP-1受体激动剂司美格鲁肽长效注射液已获中华人民共和国国家药品监督管理局批准,可以在中国开展临床试验。相较已上市的司美格鲁肽注射液每周一次的给药方式,该产品预期可延长至每月给药一次,大幅提高患者用药的依从性,具有明显临床优势。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1227653.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1960683339.HKD","IE00B031HY20.USD","01093","LU1152091754.HKD","IE00BZ08YR35.GBP","LU1951186391.HKD","LU1807302812.USD","LU1226288170.HKD","IE00B543WZ88.USD","LU0880133367.SGD","LU0067412154.USD","IE00BZ08YS42.EUR","LU1226287792.SGD","LU0501845795.SGD","BK1521","BK1576","LU1008478684.HKD","LU0326950275.SGD","03347","LU1152091168.USD","BK1515","LU1226287529.USD","BK1191","LU1993786604.SGD","LU0072913022.USD","SG9999004220.SGD","BK1583","LU1226288253.USD","IE00B5MMRT66.SGD","IE00BZ08YT58.USD","LU1226287875.USD","BK1141","LU0140636845.USD","IE0008368742.USD","IE0008369823.USD"],"gpt_icon":0},{"id":"2492128134","title":"石药集团关联交易涉及相关成员公司签续租协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2492128134","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492128134?lang=zh_cn&edition=full","pubTime":"2024-12-19 18:42","pubTimestamp":1734604956,"startTime":"0","endTime":"0","summary":"财中社12月19日电石药集团(01093)发布公告,提到相关成员公司与石药控股及内蒙古常盛制药于2024年12月19日签订了续租协议,与内蒙古长盛制药签订能源供应服务协议。续租协议涵盖多个物业,租期自2025年1月1日起为期三年。续租协议下,使用权估计资产价值约为1.59亿元。此外,能源供应服务协议由内蒙古常盛制药向石药内蒙古中诺药业提供蒸汽、电力、水等能源。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202412193273425986.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0072913022.USD","LU0880133367.SGD","LU0326950275.SGD","IE0008369823.USD","LU1993786604.SGD","LU1152091754.HKD","IE0008368742.USD","LU1226287792.SGD","IE00B031HY20.USD","LU1226287875.USD","LU1226288253.USD","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","LU1008478684.HKD","LU0140636845.USD","LU1960683339.HKD","LU0067412154.USD","LU1226287529.USD","BK1515","BK1191","LU0501845795.SGD","BK1521","LU1807302812.USD","LU1226288170.HKD","01093","LU1951186391.HKD","SG9999004220.SGD","IE00B543WZ88.USD","IE00B5MMRT66.SGD","IE00BZ08YR35.GBP","LU1152091168.USD"],"gpt_icon":0},{"id":"2492914131","title":"石药集团(01093)12月19日斥资2929.4万港元回购615万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492914131","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492914131?lang=zh_cn&edition=full","pubTime":"2024-12-19 17:14","pubTimestamp":1734599666,"startTime":"0","endTime":"0","summary":"智通财经APP讯,石药集团(01093)发布公告,于2024年12月19日斥资2929.4万港元回购股份615万股,每股回购价格为4.72-4.79港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1227076.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01093","BK1515","SG9999004220.SGD","IE0008368742.USD","BK1191","IE00BZ08YR35.GBP","LU0326950275.SGD","LU1152091168.USD","LU1226287875.USD","LU0880133367.SGD","LU1008478684.HKD","IE00BZ08YS42.EUR","LU1951186391.HKD","IE00B031HY20.USD","IE00BZ08YT58.USD","LU1226287792.SGD","LU1960683339.HKD","IE00B543WZ88.USD","LU1226288170.HKD","LU1226288253.USD","LU0140636845.USD","LU0501845795.SGD","LU0067412154.USD","LU1226287529.USD","IE00B5MMRT66.SGD","IE0008369823.USD","LU0072913022.USD","LU1993786604.SGD","LU1807302812.USD","LU1152091754.HKD","BK1521"],"gpt_icon":0},{"id":"2492716071","title":"石药集团12月18日获南向资金加仓2993.85万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492716071","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492716071?lang=zh_cn&edition=full","pubTime":"2024-12-19 09:30","pubTimestamp":1734571813,"startTime":"0","endTime":"0","summary":"12月18日, 南向资金增持石药集团2993.85万股。截止当日收盘,港股通共持有石药集团217393.34万股,占流通股18.67%。港股通增持金额前五个股分别为中国移动、工商银行、建设银行、中国海洋石油、中国平安。石药集团近5个交易日下跌5.38%,港股通累计增持5624.06万股;近20个交易日下跌8.83%,港股通累计增持5140.10万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219093242ab83277d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219093242ab83277d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0326950275.SGD","LU1152091168.USD","BK1521","LU1226287529.USD","LU1951186391.HKD","LU1960683339.HKD","IE00BZ08YR35.GBP","SG9999004220.SGD","LU1226288253.USD","IE00BZ08YT58.USD","LU1993786604.SGD","LU1226287792.SGD","LU0067412154.USD","LU1226288170.HKD","IE0008368742.USD","IE0008369823.USD","BK1515","LU1226287875.USD","LU0140636845.USD","01093","LU0880133367.SGD","BK1191","LU1152091754.HKD","LU0072913022.USD","IE00B031HY20.USD","IE00B5MMRT66.SGD","IE00BZ08YS42.EUR","LU1807302812.USD","IE00B543WZ88.USD","LU0501845795.SGD","LU1008478684.HKD"],"gpt_icon":0},{"id":"2492906801","title":"石药集团回购620万股股份 总金额2927万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492906801","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492906801?lang=zh_cn&edition=full","pubTime":"2024-12-18 18:23","pubTimestamp":1734517427,"startTime":"0","endTime":"0","summary":"财中社12月18日电石药集团(01093)发布公告,2024年12月18日,公司回购股份620万股,回购金额为2927万港元。根据回购授权的决议,公司可回购的股份总数为11.9亿股,已回购股份2.83亿股,占回购授权决议通过时已发行股份的2.377%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202412183272204210.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE00B031HY20.USD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","IE00BZ08YR35.GBP","BK1191","LU1152091754.HKD","LU0072913022.USD","IE00BZ08YS42.EUR","IE0008369823.USD","SG9999004220.SGD","LU1226287529.USD","LU1226288170.HKD","BK1521","LU1807302812.USD","LU1993786604.SGD","IE00BZ08YT58.USD","LU0326950275.SGD","LU1226288253.USD","LU1960683339.HKD","LU1951186391.HKD","BK1515","LU0140636845.USD","LU1226287792.SGD","LU0067412154.USD","01093","LU1008478684.HKD","LU1152091168.USD","LU1226287875.USD","LU0501845795.SGD","LU0880133367.SGD","IE0008368742.USD"],"gpt_icon":0},{"id":"2492970789","title":"石药集团(01093)12月18日耗资2927万港元回购620万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492970789","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492970789?lang=zh_cn&edition=full","pubTime":"2024-12-18 17:52","pubTimestamp":1734515558,"startTime":"0","endTime":"0","summary":"智通财经APP讯,石药集团(01093)公布,2024年12月18日耗资2927万港元回购620万股股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1226570.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1951186391.HKD","LU0072913022.USD","01093","BK1515","LU1960683339.HKD","LU1993786604.SGD","LU0326950275.SGD","BK1191","LU0067412154.USD","IE00B031HY20.USD","LU1226288170.HKD","SG9999004220.SGD","IE00BZ08YT58.USD","IE0008369823.USD","IE0008368742.USD","IE00BZ08YS42.EUR","LU1152091168.USD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","LU1807302812.USD","LU0880133367.SGD","BK1521","LU0501845795.SGD","LU1226287529.USD","LU1152091754.HKD","LU1226288253.USD","LU0140636845.USD","LU1226287792.SGD","LU1226287875.USD","IE00BZ08YR35.GBP","LU1008478684.HKD"],"gpt_icon":0},{"id":"2492036979","title":"石药(01093.HK)回购620万股 涉资2,927万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492036979","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492036979?lang=zh_cn&edition=full","pubTime":"2024-12-18 17:52","pubTimestamp":1734515520,"startTime":"0","endTime":"0","summary":"石药(01093.HK) 今日(18日)于联交所回购620万股,每股作价介乎4.67至4.75元,涉资约2,927万元。自购回授权决议(5月28日)通过后,公司累计购回约2.83亿股,占已发行股本约2.377%。(ha/u)(港股报价延迟最少十五分钟。沽空资料截至 2024-12-18 16:25。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230531121548386_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230531121548386_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1405021/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU0140636845.USD","LU1226287792.SGD","LU0501845795.SGD","SG9999004220.SGD","LU0067412154.USD","LU1226288253.USD","01093","IE00BZ08YT58.USD","IE00BZ08YS42.EUR","BK1515","LU1993786604.SGD","LU0326950275.SGD","BK1191","BK1521","LU1226287875.USD","LU1152091754.HKD","LU0072913022.USD","LU1807302812.USD","LU1152091168.USD","LU1226288170.HKD","IE00B543WZ88.USD","IE00B5MMRT66.SGD","LU1951186391.HKD","LU0880133367.SGD","IE00B031HY20.USD","IE0008368742.USD","IE00BZ08YR35.GBP","IE0008369823.USD","LU1960683339.HKD","LU1226287529.USD","LU1008478684.HKD"],"gpt_icon":0},{"id":"2492932666","title":"石药集团再度交易临床初期创新药产品,业绩承压下或调整研发策略","url":"https://stock-news.laohu8.com/highlight/detail?id=2492932666","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492932666?lang=zh_cn&edition=full","pubTime":"2024-12-17 18:27","pubTimestamp":1734431253,"startTime":"0","endTime":"0","summary":"仍需面对集采承压在今年第三季度,石药集团面临业绩下滑。石药集团前三季度成药业务收入同比下降3.5%,根据三季报中分析,成药业务收入下降主要受到集采和医保控费的影响。第十批药品国家集采中,石药集团有15款产品纳入,含石药集团欧意药业8个、石药集团中诺药业4个、石药银湖制药3个。预计随着多美素在国采中标降价后,石药集团的营收将受到进一步挑战。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217183235a1f58bf9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217183235a1f58bf9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","IE00B031HY20.USD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","IE00BZ08YR35.GBP","BK1191","LU1152091754.HKD","LU0072913022.USD","IE00BZ08YS42.EUR","IE0008369823.USD","SG9999004220.SGD","LU1226287529.USD","LU1226288170.HKD","BK1521","LU1807302812.USD","LU1993786604.SGD","IE00BZ08YT58.USD","LU0326950275.SGD","LU1226288253.USD","BK1574","LU1960683339.HKD","LU1951186391.HKD","06978","LU0140636845.USD","LU0880133367.SGD","LU0067412154.USD","LU1226287792.SGD","01093","LU1008478684.HKD","LU1152091168.USD","LU1226287875.USD","LU0501845795.SGD","BK1515","IE0008368742.USD"],"gpt_icon":0},{"id":"2492593677","title":"石药集团(01093)12月17日斥资2932.5万港元回购630万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492593677","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492593677?lang=zh_cn&edition=full","pubTime":"2024-12-17 17:50","pubTimestamp":1734429044,"startTime":"0","endTime":"0","summary":"智通财经APP讯,石药集团(01093)发布公告,于2024年12月17日,该公司斥资2932.5万港元回购630万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1226030.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0072913022.USD","LU0880133367.SGD","LU0326950275.SGD","IE0008369823.USD","LU1993786604.SGD","LU1152091754.HKD","IE0008368742.USD","LU1226287792.SGD","IE00B031HY20.USD","LU1226287875.USD","LU1226288253.USD","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","LU1008478684.HKD","LU0140636845.USD","LU1960683339.HKD","LU0067412154.USD","LU1226287529.USD","BK1515","BK1191","LU0501845795.SGD","BK1521","LU1807302812.USD","LU1226288170.HKD","01093","LU1951186391.HKD","SG9999004220.SGD","IE00B543WZ88.USD","IE00B5MMRT66.SGD","IE00BZ08YR35.GBP","LU1152091168.USD"],"gpt_icon":0},{"id":"2492981155","title":"石药集团(01093)出现大手买入110万股,成交价$4.65,涉资511.5万","url":"https://stock-news.laohu8.com/highlight/detail?id=2492981155","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492981155?lang=zh_cn&edition=full","pubTime":"2024-12-17 15:12","pubTimestamp":1734419520,"startTime":"0","endTime":"0","summary":"[大手成交]石药集团(01093)在下午03:12出现大手买入,成交量为110万,成交价为港币$4.65,涉资511.5万。至目前为止,股价升0.432%,今日最高价为$4.7,而最低价为$4.59,总成交量为8.041千万股,总成交金额港币$3.741亿。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145552499_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145552499_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2412174993/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU1226287529.USD","IE00BZ08YT58.USD","LU1807302812.USD","IE00B031HY20.USD","IE00BZ08YR35.GBP","LU0140636845.USD","BK1191","01093","LU0326950275.SGD","LU1993786604.SGD","LU1152091754.HKD","LU1008478684.HKD","IE0008368742.USD","BK1521","LU1226288253.USD","LU1226287792.SGD","LU1152091168.USD","LU1960683339.HKD","BK1515","IE00B543WZ88.USD","LU1951186391.HKD","IE0008369823.USD","IE00BZ08YS42.EUR","SG9999004220.SGD","IE00B5MMRT66.SGD","LU0501845795.SGD","LU0072913022.USD","LU1226287875.USD","LU0067412154.USD","LU1226288170.HKD","LU0880133367.SGD"],"gpt_icon":0},{"id":"2491666232","title":"蔡东晨增持石药集团(01093)100万股 每股作价约4.80港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491666232","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491666232?lang=zh_cn&edition=full","pubTime":"2024-12-16 18:55","pubTimestamp":1734346513,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新资料显示,12月13日,蔡东晨增持石药集团(01093)100万股,每股作价为4.798港元,总金额约为479.8万港元。增持后最新持股数目约为28.56亿股,最新持股比例为24.54%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1225512.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00B031HY20.USD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","IE00BZ08YR35.GBP","BK1191","LU1152091754.HKD","LU0072913022.USD","IE00BZ08YS42.EUR","IE0008369823.USD","SG9999004220.SGD","LU1226287529.USD","LU1226288170.HKD","BK1521","LU1807302812.USD","LU1993786604.SGD","IE00BZ08YT58.USD","LU0326950275.SGD","LU1226288253.USD","LU1960683339.HKD","LU1951186391.HKD","BK1515","LU0140636845.USD","LU1226287792.SGD","LU0067412154.USD","01093","LU1008478684.HKD","LU1152091168.USD","LU1226287875.USD","LU0501845795.SGD","LU0880133367.SGD","IE0008368742.USD"],"gpt_icon":0},{"id":"2491666503","title":"石药集团回购630万股 支付2936万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491666503","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491666503?lang=zh_cn&edition=full","pubTime":"2024-12-16 18:39","pubTimestamp":1734345583,"startTime":"0","endTime":"0","summary":"财中社12月16日电石药集团(01093)发布公告,报告了截至2024年12月16日的股份变动情况。根据公告,公司的已发行股份总数在此期间保持不变,均为116.38亿股,其中不包括库存股份。在股份回购方面,公司在2024年12月16日回购了630万股,回购平均价格为4.6598港元。此前在2024年12月13日,公司也回购了620万股,回购平均价格为4.8126港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202412163269540358.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1515","IE00BZ08YT58.USD","LU1226287792.SGD","IE00B031HY20.USD","LU0072913022.USD","IE00BZ08YS42.EUR","LU1226288170.HKD","IE00BZ08YR35.GBP","LU1960683339.HKD","LU0326950275.SGD","IE00B5MMRT66.SGD","LU1152091168.USD","IE00B543WZ88.USD","LU1951186391.HKD","LU0501845795.SGD","01093","LU0140636845.USD","LU1152091754.HKD","IE0008369823.USD","LU1008478684.HKD","LU1226287529.USD","LU1226287875.USD","SG9999004220.SGD","IE0008368742.USD","LU0067412154.USD","LU1807302812.USD","BK1191","BK1521","LU1993786604.SGD","LU1226288253.USD","LU0880133367.SGD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cspc.com.hk","stockEarnings":[{"period":"1week","weight":0.0021},{"period":"1month","weight":-0.0768},{"period":"3month","weight":-0.0101},{"period":"6month","weight":-0.2208},{"period":"1year","weight":-0.2789},{"period":"ytd","weight":-0.3196}],"compareEarnings":[{"period":"1week","weight":-0.0125},{"period":"1month","weight":0.0008},{"period":"3month","weight":0.0801},{"period":"6month","weight":0.0939},{"period":"1year","weight":0.1865},{"period":"ytd","weight":0.1568}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"石药集团有限公司是一家主要从事生产及销售药品的投资控股公司。该公司通过三个分部运营其业务。成药分部从事研发、生产及销售药品以及授权业务。原料产品分部从事生产及销售粉状维生素C及抗生素产品。功能食品及其他分部从事制造及销售功能食品产品(包括咖啡因食物添加剂、无水葡萄糖、阿卡波糖及维生素C含片)、提供医疗服务及其他。该公司的产品治疗领域包括神经系统、抗肿瘤、抗感染、心血管、呼吸系统、消化代谢等其他领域。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.533333,"avgChangeRate":0.007828},{"month":2,"riseRate":0.733333,"avgChangeRate":0.098085},{"month":3,"riseRate":0.466667,"avgChangeRate":0.019763},{"month":4,"riseRate":0.6,"avgChangeRate":0.056385},{"month":5,"riseRate":0.6,"avgChangeRate":0.038129},{"month":6,"riseRate":0.333333,"avgChangeRate":0.004615},{"month":7,"riseRate":0.354839,"avgChangeRate":0.000119},{"month":8,"riseRate":0.419355,"avgChangeRate":0.009776},{"month":9,"riseRate":0.516129,"avgChangeRate":0.002662},{"month":10,"riseRate":0.580645,"avgChangeRate":0.016021},{"month":11,"riseRate":0.451613,"avgChangeRate":0.005451},{"month":12,"riseRate":0.483871,"avgChangeRate":-0.015369}],"exchange":"SEHK","name":"石药集团","nameEN":"CSPC PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"石药集团(01093)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供石药集团(01093)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"石药集团,01093,石药集团股票,石药集团股票老虎,石药集团股票老虎国际,石药集团行情,石药集团股票行情,石药集团股价,石药集团股市,石药集团股票价格,石药集团股票交易,石药集团股票购买,石药集团股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"石药集团(01093)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供石药集团(01093)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}